Patient prognosis and prediction model for taking Kampo formulas in dysmenorrhea: An observational study

Author:

Maeda-Minami Ayako12,Kawamoto Ayako3,Yoshino Tetsuhiro2ORCID,Yokoyama Yuta3,Suzuki Sayo3,Horiba Yuko2,Nakamura Tomonori3,Mimura Masaru24,Watanabe Kenji2

Affiliation:

1. Faculty of Pharmaceutical Sciences, Tokyo University of Science, Chiba, Japan

2. Center for Kampo Medicine, Keio University School of Medicine, Tokyo, Japan

3. Division of Pharmaceutical Care Sciences, Center for Social Pharmacy and Pharmaceutical Care Science, Faculty of Pharmacy, Keio University, Tokyo, Japan

4. Department of Neuropsychiatry, Keio University School of Medicine, Tokyo, Japan.

Abstract

Two representative Kampo formulas, keishibukuryogan and tokishakuyakusan, are frequently prescribed for patients with dysmenorrhea. We previously constructed a model that could predict which of these 2 formulas was most suitable, which is based on 4 subjective symptoms and 3 objective signs. To evaluate the prognosis of patients with dysmenorrhea using the established prediction model and assess the treatment outcomes between those treated in accordance with the prediction model and those who received various other treatments. In this retrospective, observational study, we included patients with menstrual pain who visited the Kampo Clinic at the Keio University Hospital for the first time between October 2014 and December 2020. These patients were monitored over a 90-day follow-up period. Participants were categorized into 2 groups: model-accordance and various-options. The progression of visual analogue scale (VAS) values was evaluated by determining the slopes from regression analysis between these 2 groups, with changes corroborated by the medical records. The study comprised 57 patients: 37 in the model-accordance group and 20 in the various-options group. Notably, the various-options group reported a significantly higher number of subjective symptoms (P = .03). The VAS value showed a decline, as indicated by the negative slope value of the regression line, across both groups – irrespective of their classification. There were no significant differences in the occurrence of adverse events between the 2 groups. The prognosis of patients with dysmenorrhea and the incidence of adverse events remained consistent, regardless of whether the treatment approach was in accordance with the prediction model or varied. Further studies are warranted to assess the prognosis when Kampo formulas are chosen based on the prediction model in the various-options population.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

General Medicine

Reference33 articles.

1. Dysmenorrhea.;McKenna;Am Fam Physician,2021

2. Deciphering the pharmacological mechanisms of Guizhi-Fuling capsule on primary dysmenorrhea through network pharmacology.;Zhang;Front Pharmacol,2021

3. Primary dysmenorrhea: diagnosis and therapy.;Ferries-Rowe;Obstet Gynecol,2020

4. Dysmenorrhea in adolescents and young adults: an update on pharmacological treatments and management strategies.;Harel;Expert Opin Pharmacother,2012

5. Diagnosis and initial management of dysmenorrhea.;Osayande;Am Fam Physician,2014

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3